<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F19454B9-245C-4910-A9D3-8327F22C2DCA"><gtr:id>F19454B9-245C-4910-A9D3-8327F22C2DCA</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>W</gtr:otherNames><gtr:surname>Milling</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900270"><gtr:id>B0964F0E-7585-498E-B49A-E552208C73D2</gtr:id><gtr:title>The Functions of Migrating Dendritic Cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900270</gtr:grantReference><gtr:abstractText>The intestine has a surface area nearly two hundred times greater than the skin, and is exposed to many pathogenic micro-organisms. It requires an effective immune response to protect it from infections. On the other hand, immune responses must not be made against the harmless bacteria and food proteins that are also present. When they occur, these inappropriate responses have serious consequences, leading to inflammatory bowel diseases or food allergies. To ensure our health, the balance between ?immunity? and ?tolerance? must be maintained.
A critical cell for maintaining this balance is the dendritic cell (DC). DCs migrate continually, in lymph, carrying information about the intestine to the immune cells in the mesenteric lymph nodes (MLN). On reaching the MLN, DCs interact with T lymphocytes. This interaction is thought to control whether immunity or tolerance will occur. Understanding how DCs control these processes is likely to be highly beneficial in the design of oral vaccines or prevention of inflammatory bowel diseases. However, study of migrating DCs has been difficult because they cannot easily be separated from other cells in the MLNs. The only way to collect cells which are certain to be migrating DCs is by surgery, which is used to collect the DC-containing lymph. Previously this surgery has only been possible in large animals.
We have developed humane surgical techniques to collect migrating DCs from mice, and to return them to the MLNs. This will enable us, for the first time, to study these cells and their interactions with T cells, using the sophisticated immunological techniques and resources that are only available in mice. We are currently the only group in the world able to collect migrating DCs from mouse lymph. We believe that the study of these cells will generate important information about how immune responses are controlled.</gtr:abstractText><gtr:technicalSummary>The intestinal immune system must maintain a delicate balancing act, retaining the ability to respond to invading pathogens while also preventing unwanted responses against harmless commensal organisms and food antigens. Dendritic cells (DCs) continually migrate, via lymph, from the intestine to the mesenteric lymph nodes (MLNs), where they prime T cells and direct their differentiation. They are therefore thought to be central to the control of the balance between tolerance and immunity. Understanding this balance is central to the development of oral vaccines, and therapies to prevent or control both food allergies and inflammatory bowel diseases. Study of the immunology of migrating DCs has been hampered by the fact that they cannot be definitively identified in intestinal tissues or in the MLN; unique markers have not been identified. Their properties have been studied in the lymph of rats and larger animals, but these investigations are limited by a lack of immunological reagents, inbred strains, and transgenic animals.
To investigate how migrating DCs interact with T cells and control the balance between tolerance and immunity, we have applied our knowledge of rat surgery to master mesenteric lymphadenectomy and thoracic duct cannulation techniques in the mouse. We have also adapted a technique for intra-lymphatic injection of cells. We are currently the only group in the world able to collect and purify bona fide migrating intestinal DCs. We will use these techniques to address critical questions about the functions of these cells, their fate in vivo, and their interactions with T cells.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>379499</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boehringer Ingelheim</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>BI</gtr:description><gtr:id>CF7D6C42-F763-40DF-874C-EB4D9FB8AE97</gtr:id><gtr:impact>We have provided samples that has enabled a specific compound to progress towards clinical trials.</gtr:impact><gtr:outcomeId>hCRm6h2vdU1-1</gtr:outcomeId><gtr:partnerContribution>The partners will be providing deep sequencing and transcriptomics platforms, and bioinformatics support for the collaboration.</gtr:partnerContribution><gtr:piContribution>We will be generating samples and data, and analysing the outputs in collaboration with Boehringer,</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BSI: Bite-Sized Immunology</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D96C0B34-CDF3-41A1-A8E5-D401DDE426FD</gtr:id><gtr:impact>I contributed two articles to the British Society for Immunology's &amp;quot;Bite Sized Immunology&amp;quot;. These are linked from the Society's home page. I do not know how many people have read them.

I understand that this resource, supported by the British Society for Immunology, has had many many page views. I regret that I do not know the numbers.</gtr:impact><gtr:outcomeId>bkzij9NVs7p</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://bitesized.immunology.org/</gtr:url><gtr:year>2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit to GU</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6DA39BD6-CB8C-43D0-AA23-5F7C9D753F92</gtr:id><gtr:impact>Over two hundred primary school children attended workshops at the University, some of which were facilitated by members from my laboratory. Much interest was generated!

-</gtr:impact><gtr:outcomeId>KXpugqAK6SA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AR UK Project Grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>20ADE759-30B1-4101-97F9-19857466A378</gtr:id><gtr:outcomeId>GV82VpQctKx0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120099</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Arthritis Research UK Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:fundingRef>19853</gtr:fundingRef><gtr:id>F64D0005-F2F3-4964-A445-06A631044FF7</gtr:id><gtr:outcomeId>FLuCjTis2Nf</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We perform thoracic duct cannulations to collect cells from live rats and mice, and have significantly refined the necessary techniques.</gtr:description><gtr:id>D1D2C8D9-1EAA-4149-B31B-C4BF4EC63102</gtr:id><gtr:impact>Projects involving the refined techniques have been submitted to funding agencies in the USA and Switzerland.</gtr:impact><gtr:outcomeId>ecoLZyVCft2</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Thoracic duct cannulation techniques</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7BA8534B-214A-48A2-994D-9AB6676C4585</gtr:id><gtr:title>D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0331f9f7036ea49437976540ae3a31b"><gtr:id>f0331f9f7036ea49437976540ae3a31b</gtr:id><gtr:otherNames>Lee KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>UmxwL4vxFXN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F269CC8-3A14-42B4-9DEE-62F6C9FCAF9F</gtr:id><gtr:title>Subsets of migrating intestinal dendritic cells.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ded8f7e17fd038e6b4ff632f8379c32a"><gtr:id>ded8f7e17fd038e6b4ff632f8379c32a</gtr:id><gtr:otherNames>Milling S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>pm_12949_29_20193024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>960047A4-D9A7-43FA-A597-87D73C94ACF9</gtr:id><gtr:title>Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5592beea0c2db7a7ff847adea6dcf6a7"><gtr:id>5592beea0c2db7a7ff847adea6dcf6a7</gtr:id><gtr:otherNames>Utriainen L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>pm_12949_29_22674414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF65E911-5E64-432A-B41D-462A3FF54A29</gtr:id><gtr:title>Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af6afdc4db69f371cccc1508dcdbf087"><gtr:id>af6afdc4db69f371cccc1508dcdbf087</gtr:id><gtr:otherNames>Cerovic V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>pm_12949_29_22718260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBC0FFE3-5A4B-4C07-8C5B-7580B10E5EC0</gtr:id><gtr:title>Identification and phenotypic characterization of ?d T cells in rat lymph.</gtr:title><gtr:parentPublicationTitle>Research in veterinary science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d031a05dee9a6b8d033acd5a54a3f244"><gtr:id>d031a05dee9a6b8d033acd5a54a3f244</gtr:id><gtr:otherNames>Shekhar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0034-5288</gtr:issn><gtr:outcomeId>b8P9JSpRTt6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBD2E71C-274C-428A-84B7-6B148F6A5B5A</gtr:id><gtr:title>Isolation of rat intestinal lymph DC.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ded8f7e17fd038e6b4ff632f8379c32a"><gtr:id>ded8f7e17fd038e6b4ff632f8379c32a</gtr:id><gtr:otherNames>Milling S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_12949_19_19941120</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900270</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>